Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.22 (
cdc2
)
8,319
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
DNA polymerase alpha-primase is the only known eukaryotic enzyme that can start DNA replication de novo. In this study, we investigated the regulation of DNA replication by phosphorylation of DNA polymerase alpha-primase. The p180 and the
p68
subunits of DNA polymerase alpha-primase were phosphorylated using Cyclin A-, B- and E- dependent kinases. This phosphorylation did not influence its DNA polymerase activity on activated DNA, but slightly stimulated primase activity using poly(dT) single-stranded DNA (ssDNA) without changing the product length of primers. In contrast, site-specific initiation of replication on plasmid DNA containing the SV40 origin is affected: Cyclin A-
Cdk2
and Cyclin A-Cdc2 inhibited initiation of SV40 DNA replication in vitro, Cyclin B-Cdc2 had no effect and Cyclin E-
Cdk2
stimulated the initiation reaction. DNA polymerase alpha-primase that was pre-phosphorylated by Cyclin A-
Cdk2
was completely unable to initiate the SV40 DNA replication in vitro; Cyclin B-Cdc2-phosphorylated enzyme was moderately inhibited, while Cyclin E-
Cdk2
-treated DNA polymerase alpha-primase remained fully active in the initiation reaction.
...
PMID:Phosphorylation of DNA polymerase alpha-primase by cyclin A-dependent kinases regulates initiation of DNA replication in vitro. 912 53
DNA polymerase alpha-primase is known to be phosphorylated in human and yeast cells in a cell cycle-dependent manner on the p180 and
p68
subunits. Here we show that phosphorylation of purified human DNA polymerase alpha-primase by purified cyclin A/
cdk2
in vitro reduced its ability to initiate simian virus 40 (SV40) DNA replication in vitro, while phosphorylation by cyclin E/
cdk2
stimulated its initiation activity. Tryptic phosphopeptide mapping revealed a family of
p68
peptides that was modified well by cyclin A/
cdk2
and poorly by cyclin E/
cdk2
. The p180 phosphopeptides were identical with both kinases. By mass spectrometry, the
p68
peptide family was identified as residues 141 to 160. Cyclin A/
cdk2
- and cyclin A/
cdc2
-modified
p68
also displayed a phosphorylation-dependent shift to slower electrophoretic mobility. Mutation of the four putative phosphorylation sites within
p68
peptide residues 141 to 160 prevented its phosphorylation by cyclin A/
cdk2
and the inhibition of replication activity. Phosphopeptide maps of the
p68
subunit of DNA polymerase alpha-primase from human cells, synchronized and labeled in G1/S and in G2, revealed a cyclin E/
cdk2
-like pattern in G1/S and a cyclin A/
cdk2
-like pattern in G2. The slower-electrophoretic-mobility form of
p68
was absent in human cells in G1/S and appeared as the cells entered G2/M. Consistent with this, the ability of DNA polymerase alpha-primase isolated from synchronized human cells to initiate SV40 replication was maximal in G1/S, decreased as the cells completed S phase, and reached a minimum in G2/M. These results suggest that the replication activity of DNA polymerase alpha-primase in human cells is regulated by phosphorylation in a cell cycle-dependent manner.
...
PMID:Cell cycle-dependent regulation of human DNA polymerase alpha-primase activity by phosphorylation. 985 88
DNA polymerase alpha-primase (pol-prim) is the only enzyme that can start DNA replication de novo. The 180-kDa (p180) and 68-kDa (
p68
) subunits of the human four-subunit enzyme are phosphorylated by Cyclin-dependent kinases (Cdks) in a cell cycle-dependent manner. Cyclin A-
Cdk2
physically interacts with pol-prim and phosphorylates N-terminal amino acids of the p180 and the
p68
subunits, leading to an inhibition of pol-prim in initiating cell-free SV40 DNA replication. Mutation of conserved putative Cdk phosphorylation sites in the N terminus of human p180 and
p68
reduced their phosphorylation by Cyclin A-
Cdk2
in vitro. In contrast to wild-type pol-prim these mutants were no longer inhibited by Cyclin A-
Cdk2
in the initiation of viral DNA replication. Importantly, rather than inhibiting it, Cyclin A-
Cdk2
stimulated the initiation activity of pol-prim containing a triple N-terminal alanine mutant of the p180 subunit. Together these results suggest that Cyclin A-
Cdk2
executes both stimulatory and inhibitory effects on the activity of pol-prim in initiating DNA replication.
...
PMID:Multiple phosphorylation sites of DNA polymerase alpha-primase cooperate to regulate the initiation of DNA replication in vitro. 1150 43
DNA polymerase alpha (pol-alpha) is a heterotetrameric enzyme (p180-
p68
-p58-p48 in mouse) that is essential for the initiation of chain elongation during DNA replication. The catalytic (p180) and
p68
subunits of pol-alpha are phosphorylated by Cdk-cyclin complexes, with
p68
being hyperphosphorylated by cyclin-dependent kinases in G(2) phase of the cell cycle. The activity of
Cdk2
-cyclin A increases during late S phase and peaks in G(2) phase. We have now examined the role of
p68
in the interaction between the catalytic subunit of pol-alpha and hyperphosphorylated retinoblastoma protein (ppRb) and in the stimulation of the polymerase activity of pol-alpha by ppRb. With the use of recombinant proteins, we found that nonphosphorylated
p68
inhibited the stimulation of pol-alpha activity by ppRb, suggesting that
p68
might impede the association of ppRb with p180. Phosphorylation of
p68
by
Cdk2
-cyclin A greatly reduced its inhibitory effect. Immunofluorescence analysis also revealed that ppRb localized at sites of DNA replication specifically in late S phase. These results suggest that Cdk-cyclin A can phosphorylate pol-alpha which may result in a conformational change in pol-alpha facilitating its interaction with and activation by ppRb.
...
PMID:Role of the second-largest subunit of DNA polymerase alpha in the interaction between the catalytic subunit and hyperphosphorylated retinoblastoma protein in late S phase. 1693 76